Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | OCGN Ocugen, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.02 +2.0% | $14.86 -2.5% |
| StockIQ Score | 42D Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 17F | 13F |
| Fundamental | 42D | 35F |
| Growth | 40D | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Ocugen (OCGN) outperforms Ascentage Pharma (AAPG) in stability and fundamentals, scoring higher in investor (46 vs. 37), technical (41 vs. 18), and fundamental (42 vs. 35) categories. AAPG leads only in growth (50 vs. 40) and valuation (38 vs. 50), but its weak overall rating ("WEAK" vs. "MODERATE") suggests more risk. OCGN shows stronger consistency across most metrics.
